Pharmacological augmentation of endocannabinoid signaling reduces the neuroendocrine response to stress. (January 2018)

• Record Type: Journal Article
• Authors: Surkin, Pablo Nicolás; Gallino, Sofia Ludmila; Luce, Valeria; Correa, Fernando; Fernandez-Solari, Javier; De Laurentiis, Andrea
• Is Part Of: Psychoneuroendocrinology. Volume 87(2018)
• Page Start: 131
• Page End: 140
• Publication Date: 2018-01
• Subjects: Anandamide -- Cannabinoid receptor 1 -- Vanilloid receptors -- Nitric oxide -- Adrenal glands -- Corticosterone; Psychoneuroendocrinology -- Periodicals; Endocrinology -- Periodicals; Neurology -- Periodicals; Psychiatry -- Periodicals; Neuropsychoendocrinologie -- Périodiques; 616.8
• DOI: 10.1016/j.psyneuen.2017.10.015
• Languages: English
• ISSNs: 0306-4530

Abstract

Highlights: Neuroendocrine response to a psychophysical acute stress model in the adult male rat. Nitric Oxide may play a role in the regulation of restraint stress response. Endocannabinoids as mediators of hypothalamic-pituitary-adrenal axis response to stress. The endocannabinoid anandamide dampens the neuroendocrine acute stress response. Abstract: Activation of the hypothalamic-pituitary-adrenal axis (HPA) is critical for survival when the organism is exposed to a stressful stimulus. The endocannabinoid system (ECS) is currently considered an important neuromodulator involved in numerous pathophysiological processes and whose primary function is to maintain homeostasis. In the tissues constituting the HPA axis, all the components of the ECS are present and the activation of this system acts in parallel with changes in the activity of numerous neurotransmitters, including nitric oxide (NO). NO is widely distributed in the brain and adrenal glands and recent studies have shown that free radicals, and in particular NO, may play a crucial role in the regulation of stress response. Our objective was to determine the participation of the endocannabinoid and NOergic systems as probable mediators of the neuroendocrine HPA axis response to a psychophysical acute stress model in the adult male rat. Animals were pre-treated with cannabinoid receptors agonists and antagonists at central and systemic level prior to acute restraint exposure. We also performed in vitro studies incubating adrenal glands in the presence of ACTH and pharmacological compounds that modifies ECS components. Our results showed that the increase in corticosterone observed after acute restraint stress is blocked by anandamide administered at both central and peripheral level. At hypothalamic level both cannabinoid receptors (CB1 and CB2) are involved, while in the adrenal gland, anandamide has a very potent effect in suppressing ACTH-induced corticosterone release that is mainly mediated by vanilloid TRPV1 receptors. We also observed that stress significantly increased hypothalamic mRNA levels of CB1 as well as adrenal mRNA levels of TRPV1 receptor. In addition, anandamide reduced the activity of the nitric oxide synthase enzyme during stress, indicating that the anti-stress action of endocannabinoids may involve a reduction in NO production at hypothalamic and adrenal levels. In conclusion, an endogenous cannabinoid tone maintains the HPA axis in a stable basal state, which is lost with a noxious stimulus. In this case, the ECS dampens the response to stress allowing the recovery of homeostasis. Moreover, our work further contributes to in vitro evidence for a participation of the endocannabinoid system by inhibiting corticosterone release directly at the adrenal gland level.